Paul Brown
Neurology · Lubbock, TXNPI 1346204500
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 49.1% of the total. Reporting peaked in 2020 at $962 and has fallen 74.6% since, to $244 in 2025.
Across 255 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$2K
- Neurelis, Inc.$354
- UCB, Inc.$338
- AbbVie$274
- Livanova USA, Inc.$255
- Sunovion Pharmaceuticals Inc.$126
- plus $623 from 18 others
What the payments were for
- Speaking & faculty fees$662%
- Food & beverage$3,78698%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 162 | $1,898 |
| Neurelis, Inc. | 16 | $354 |
| UCB, Inc. | 18 | $338 |
| AbbVie | 13 | $274 |
| Livanova USA, Inc. | 4 | $255 |
| Sunovion Pharmaceuticals Inc. | 8 | $126 |
| Acadia Pharmaceuticals Inc | 4 | $91 |
| Acorda Therapeutics, Inc | 3 | $66 |
| GE HealthCare | 3 | $56 |
| Medtronic | 2 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $47 |
| Greenwich Biosciences, Inc. | 3 | $44 |
| Argenx US, Inc. | 2 | $41 |
| Adamas Pharmaceuticals, Inc. | 2 | $36 |
| Springworks Therapeutics, Inc. | 1 | $28 |
| Pfizer | 1 | $26 |
| Novartis | 1 | $25 |
| Zogenix Inc. | 1 | $20 |
| SK Life Science, Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Travere Therapeutics, Inc. | 4 | $17 |
| Aquestive Therapeutics, Inc. | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$102
How this compares
$3,869 in reported general payments places this provider in the 55th percentile of 1,246 neurology providers in Texas.
Other neurology in Lubbock
- Mirla AvilaLubbock$1.3M
- Katie HendleyLubbock$203K
- Henrik WilmsLubbock$117K
- Ann BassSan Antonio$1.7M
- William OndoHouston$1.4M
- Nirav PavasiaDallas$1.4M
- Michael SoileauGeorgetown$1.2M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Benjamin GreenbergDallas$773K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.